Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-18-008611

Chief Scientific Officer sold 10,000 shares at $35.98 ($359,800)

  • Chief Scientific Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Albright Charles · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-06-13 Exercise or conversion : show line 1 in the form +10,000 $16.51 $165,100 10,000 D
2018-06-13 Sale : show line 2 in the form −10,000 $35.98 $359,800 0 D
Open-market sales · 10,000 sh · avg $35.98 · $359,800

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-06-13 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −10,000 205,000 D
Loading xslF345X03/edgar.xml…